SCHEMBL6970747

SCHEMBL6970747

O=C1Sc2ccccc2C(C(=O)O)C1=O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 3/20 0.42
GRM5 P41594 2/20 0.40
ALDH1A1 P00352 3/20 0.37
GAA P10253 1/20 0.37
EDNRA P25101 2/20 0.36
EDNRB P24530 1/20 0.36
MAPT P10636 2/20 0.34
ALOX15 P16050 1/20 0.34
HTT P42858 1/20 0.34
HBB P68871 1/20 0.34
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
NPC1 O15118 1/20 0.32
PKM P14618 1/20 0.32
RAB9A P51151 1/20 0.32
BCHE P06276 1/20 0.32
ACHE P22303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5756547 0.83 GRM1 (0.51) GRM1GRM5ALDH1A1GAAEDNRA
SCHEMBL751446 0.81 GRM1 (0.50) GRM1GRM5ALDH1A1GAAEDNRA
SCHEMBL27503672 0.77 GRM1 (0.45) GRM1GRM5ALDH1A1GAABCHE
SCHEMBL6324783 0.75 ALDH1A1 (0.42) GRM1GRM5ALDH1A1GAAEDNRA
SCHEMBL8814780 0.72 GRM1 (0.43) GRM1GRM5ALDH1A1GAAMAPT
SCHEMBL11823616 0.72 GRM1 (0.45) GRM1GRM5ALDH1A1GAAHTT
SCHEMBL8817077 0.71 GRM1 (0.40) GRM1GRM5ALDH1A1GAA
SCHEMBL27502434 0.70 TYMS (0.33)
SCHEMBL8813838 0.70 BCHE (0.46) GRM1GRM5MAPTHPGDNPC1
SCHEMBL6432188 0.69 GRM1 (0.46) GRM1GRM5ALDH1A1GAABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1283837-A1 NEW THIOCHROMANE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS AstraZeneca AB (SE) 2003-02-19 EP disclosed
WO-2001087879-A1 NEW THIOCHROMANE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS ASTRAZENECA AB (SE) 2001-11-22 WO disclosed